BELLUS Health Inc.
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of chronic cough and other hypersensitization disorders. Its lead drug candidate includes BLU-5937, an oral small molecule antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of chronic cough and chronic pruritus. The company was founded in 1993 and is headquartered in Laval, Canada. Show More...
-
Website http://www.bellushealth.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 14.74 USD
-
Last Updated 06-07-2023
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -12.96 -0.67 -1.48 -0.07 -0.12 0.010 -0.11 -0.09 -0.2 -0.56 -0.66 Dividends USD Payout Ratio % * Shares Mil 2.0 6.0 9.0 13.0 13.0 13.0 16.0 19.0 34.0 47.0 50.0 Book Value Per Share * USD -28.53 -18.63 0.75 0.74 0.55 0.46 0.4 0.23 0.37 1.74 2.1 Free Cash Flow Per Share * USD -2.2 -0.82 -0.34 -0.22 -0.23 -0.16 -0.13 -0.21 -0.2 -0.31 Return on Assets % -81.92 20.24 -67.8 -3.31 -9.09 1.15 -17.9 -10.0 -21.59 -39.1 -38.85 Financial Leverage (Average) 2.75 2.44 1.99 1.66 1.16 1.08 1.05 1.09 1.04 Return on Equity % -8.61 -20.36 2.12 -25.37 -11.02 -22.98 -42.09 -40.76 Return on Invested Capital % -5.44 -21.33 1.09 -26.14 -11.32 -23.88 -43.78 -42.27 Interest Coverage -27.88 -5.27 -59.14 -5.84 -18.39 35.36 -200.18 -163.82 Current Ratio 0.73 0.95 7.34 5.2 3.7 2.87 6.84 11.8 18.73 12.38 15.47 Quick Ratio 0.67 0.82 6.99 4.92 3.41 2.3 6.28 11.58 18.3 11.99 15.01 Debt/Equity 0.84 0.54